This article was originally published in The Gray Sheet
Study published in May 28 New England Journal of Medicine concludes that isolated rises in prostate-specific antigen levels should be confirmed with a follow-up test before recommending prostate biopsy. James Eastham, MD, et al., Polyp Prevention Trial Study, note that the protocol "may reduce the number of unnecessary procedures markedly." While PSA testing combined with digital rectal exam often is used for early cancer detection, the U.S. Preventive Services Task Force does not endorse the procedure (1"The Gray Sheet" Dec. 9, 2002, p. 14)...
You may also be interested in...
The U.S. Preventive Services Task Force will no longer recommend against routine prostate cancer screening, but cautions that the benefits have not been fully demonstrated
Considerable value has been assigned to the companies developing coronavirus vaccines. Multiple suppliers and a met clinical need may erode much of that value after the pandemic.
Guidelines outline permitted practices and patient safeguards for both physicians and technology platforms.